company background image
STIM

Neuronetics NasdaqGM:STIM Stock Report

Last Price

US$5.83

Market Cap

US$158.7m

7D

-3.3%

1Y

69.0%

Updated

27 Jan, 2023

Data

Company Financials +

STIM Stock Overview

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.

STIM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Neuronetics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Neuronetics
Historical stock prices
Current Share PriceUS$5.83
52 Week HighUS$6.95
52 Week LowUS$1.98
Beta2.12
1 Month Change-7.61%
3 Month Change78.29%
1 Year Change68.99%
3 Year Change60.61%
5 Year Changen/a
Change since IPO-79.01%

Recent News & Updates

Recent updates

Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Sep 06
Is Neuronetics (NASDAQ:STIM) Using Debt Sensibly?

Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Jun 08
Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?

Jan 19
Is Neuronetics (NASDAQ:STIM) Weighed On By Its Debt Load?

Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way?

Oct 14
Is Neuronetics (NASDAQ:STIM) Using Debt In A Risky Way?

Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Jul 05
Is Neuronetics (NASDAQ:STIM) A Risky Investment?

Can You Imagine How Elated Neuronetics' (NASDAQ:STIM) Shareholders Feel About Its 980% Share Price Gain?

Mar 18
Can You Imagine How Elated Neuronetics' (NASDAQ:STIM) Shareholders Feel About Its 980% Share Price Gain?

This Insider Has Just Sold Shares In Neuronetics, Inc. (NASDAQ:STIM)

Feb 11
This Insider Has Just Sold Shares In Neuronetics, Inc. (NASDAQ:STIM)

Should You Take Comfort From Insider Transactions At Neuronetics, Inc. (NASDAQ:STIM)?

Jan 26
Should You Take Comfort From Insider Transactions At Neuronetics, Inc. (NASDAQ:STIM)?

What Is The Ownership Structure Like For Neuronetics, Inc. (NASDAQ:STIM)?

Dec 28
What Is The Ownership Structure Like For Neuronetics, Inc. (NASDAQ:STIM)?

Health Check: How Prudently Does Neuronetics (NASDAQ:STIM) Use Debt?

Nov 30
Health Check: How Prudently Does Neuronetics (NASDAQ:STIM) Use Debt?

Shareholder Returns

STIMUS Medical EquipmentUS Market
7D-3.3%-0.1%2.3%
1Y69.0%-9.6%-9.7%

Return vs Industry: STIM exceeded the US Medical Equipment industry which returned -8.2% over the past year.

Return vs Market: STIM exceeded the US Market which returned -8.5% over the past year.

Price Volatility

Is STIM's price volatile compared to industry and market?
STIM volatility
STIM Average Weekly Movement8.9%
Medical Equipment Industry Average Movement8.8%
Market Average Movement6.9%
10% most volatile stocks in US Market17.3%
10% least volatile stocks in US Market2.9%

Stable Share Price: STIM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: STIM's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2001198Keith Sullivanhttps://www.neurostar.com

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.

Neuronetics, Inc. Fundamentals Summary

How do Neuronetics's earnings and revenue compare to its market cap?
STIM fundamental statistics
Market CapUS$158.70m
Earnings (TTM)-US$36.50m
Revenue (TTM)US$62.03m

2.6x

P/S Ratio

-4.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
STIM income statement (TTM)
RevenueUS$62.03m
Cost of RevenueUS$14.63m
Gross ProfitUS$47.40m
Other ExpensesUS$83.90m
Earnings-US$36.50m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.34
Gross Margin76.41%
Net Profit Margin-58.85%
Debt/Equity Ratio56.8%

How did STIM perform over the long term?

See historical performance and comparison